Schwabe Stefan K.f. - Net Worth and Insider Trading
Schwabe Stefan K.f. Net Worth
The estimated net worth of Schwabe Stefan K.f. is at least $87,096 dollars as of 2024-09-24. Schwabe Stefan K.f. is the Executive Vice President & CMO of Supernus Pharmaceuticals Inc and owns about 2,772 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $87,096. Details can be seen in Schwabe Stefan K.f.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Schwabe Stefan K.f. has not made any transactions after 2020-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Schwabe Stefan K.f.
Schwabe Stefan K.f. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Schwabe Stefan K.f. owns 1 companies in total, including Supernus Pharmaceuticals Inc (SUPN) .
Click here to see the complete history of Schwabe Stefan K.f.’s form 4 insider trades.
Insider Ownership Summary of Schwabe Stefan K.f.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SUPN | Supernus Pharmaceuticals Inc | 2020-12-21 | Executive Vice President R&D |
Schwabe Stefan K.f. Latest Holdings Summary
Schwabe Stefan K.f. currently owns a total of 1 stock. Schwabe Stefan K.f. owns 2,772 shares of Supernus Pharmaceuticals Inc (SUPN) as of December 21, 2020, with a value of $87,096.
Latest Holdings of Schwabe Stefan K.f.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SUPN | Supernus Pharmaceuticals Inc | 2020-12-21 | 2,772 | 31.42 | 87,096 |
Holding Weightings of Schwabe Stefan K.f.
Schwabe Stefan K.f. Form 4 Trading Tracker
According to the SEC Form 4 filings, Schwabe Stefan K.f. has made a total of 2 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 46,347 shares on December 21, 2020, which brought Schwabe Stefan K.f. around $1 Million.
Insider Trading History of Schwabe Stefan K.f.
- 1
Schwabe Stefan K.f. Trading Performance
Schwabe Stefan K.f. Ownership Network
Schwabe Stefan K.f. Owned Company Details
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
Schwabe Stefan K.f. is the Executive Vice President R&D of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, Schwabe Stefan K.f. made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 98,505 shares made by Padmanabh P. Bhatt , a net sale of 21,235 shares made by Tami Tillotson Martin , and a net sale of 13,886 shares made by Georges Gemayel .
In summary, during the past 3 months, insiders sold 13,886 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 13,886 shares. During the past 18 months, 146,329 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 146,329 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
Schwabe Stefan K.f. Mailing Address
Above is the net worth, insider trading, and ownership report for Schwabe Stefan K.f.. You might contact Schwabe Stefan K.f. via mailing address: C/o Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville Md 20850.